Smith, an assistant professor of computer science, recently published a study in Journal of Proteome Research on how mass spec users see their software options.
The multiplexed proteomic approach could offer better sensitivity and accuracy than existing methods while working with a wider range of instrumentation.
The companies are aiming to codevelop, comarket, and improve the integration of the Evosep One LC system with Bruker's timsTOF Pro mass spec.
The approach allows for more confident identification of peptide variants and enables deeper and broader peptide coverage, according to the researchers.
The UK startup believes protein PTMs can provide insights into protein damage that can be used to address common late-onset conditions like atherosclerosis.
Enthusiasm for dried blood spot samples is building among clinical proteomic researchers and companies, but recent work suggests technical hurdles remain.
The API assets could enable more data-intensive, machine learning-based approaches to healthcare, said a principal at DiscernDx investor Khosla Ventures.
The test measures the multiple myeloma marker M protein and could prove more sensitive and less susceptible to interferences than existing assays.
They acknowledge that while the technical hurdles of proteomic test development have become manageable, commercialization is still a major challenge.
The proteomics firm is swapping 4 million of its shares for a 10 percent interest in CPR with the goal of moving into clinical trials and related research.
The firm posted revenues of $530.5 million, with organic growth at 4 percent and acquisitions and currency effects adding 4 percent and 5 percent, respectively.
The companies will offer a system for the identification and quantitation of metabolites in biological samples.
Developed by researchers at the University of Michigan, the software could help drive uptake of ion mobility mass spec within the top-down proteomics field.
The partners are aiming to develop mass spectrometry-based data analysis software for use in lipidomics research.
At the JP Morgan conference, Thermo discussed new additions to its sequencing business, a clinical mass spec that will launch this year, and progress in China.
High-throughput DIA mass spec workflows for PTM analysis could allow researchers to, for instance, do more extensive characterization of cell signaling.
Researchers found that 98 percent of the identifications the system provided were correct, indicating the usefulness of the platform in clinical mycology.
The company entered an agreement with JP Morgan Chase that provides a five-year unsecured $300 million term loan and a $1.5 billion revolving facility.
The work demonstrates the ability of mass spectrometry to profile protein complexes in their native states in great detail and with relatively high throughput.
The method from University of Texas researchers combines carbamylation of proteins prior to trypsin digestion with ultraviolet photodissociation mass spec.
The US Patent and Trademark Office is opening another interference proceeding in the CRISPR patent fight.
There's increasing genetic evidence that a number of ancient hominins may have contributed to the human gene pool, according to Discover's The Crux blog.
The Japan News writes that Japan needs to seize the opportunity to ensure that a wide number of people benefit from personalized cancer treatments.
In Cell this week: messenger RNA expression and translation, RNA localization atlas, and more.